Mallinckrodt Pharmaceuticals
MNK
$0.34
Share price
0.00%
Change (1 day)
-93.81%
Change (1 year)
Categories
Mallinckrodt Pharmaceuticals (MNK) - Cash on Hand
Cash on Hand as of June 2023 : $0.48 B
According to Mallinckrodt Pharmaceuticals
's latest financial reports the company has $0.48 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Mallinckrodt Pharmaceuticals - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.40 B | -69.55% |
| 2021-12-31 | $1.34 B | 25.63% |
| 2020-12-31 | $1.07 B | 35.36% |
| 2019-12-31 | $0.79 B | 126.68% |
| 2018-12-31 | $0.34 B | -72.33% |
| 2017-12-31 | $1.26 B | |
| 2016-09-30 | $0.28 B | -23.34% |
| 2015-09-30 | $0.36 B | -48.3% |
| 2014-09-30 | $0.70 B | 156.91% |
| 2013-09-30 | $0.27 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 4,670.50% | 🇺🇸 USA |
 General Electric GE | $22.18 B | 4,515.90% | 🇺🇸 USA |
 Zogenix ZGNX | N/A | N/A | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 571.24% | 🇮🇱 Israel |